Spexis Ltd. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of respiratory therapeutics. The firm focuses on rare, chronic respiratory diseases (CRD) and chronic lung infections in cystic fibrosis. Its product pipeline includes ColiFin, Inhaled Murepavadin, Balixafortide (POL6326), OMPTA, EBX-002, and POL6014 (Lonodelestat). The company was founded by Daniel Obrecht and Jean-Pierre Obrecht in 1996 and is headquartered in Allschwil, Switzerland.

Innolife Oy is a private company headquartered in Finland. The firm engages in letting of dwellings.

Riken Corp. engages in the manufacture and sale of engine and vehicular components. It operates through the Automotive and Machinery Parts, and Others segments. The Automotive and Machinery Parts segment deals with the company's core products such as piston rings, camshafts, seal rings for transmissions, high-grade cast iron products, and valve lifters. The Others segment includes plumbing equipment business, Electromagnetic Compatibility (EMC) business, and thermal engineering business, The company was founded by Masatoshi Okochi in November 1927 and is headquartered in Tokyo, Japan.

ABION, Inc. engages in the development of biopharmaceuticals for treating incurable diseases. Its products include protein, nucleic acid, and antibody therapeutics. The company was founded on April 16, 2007 and is headquartered in Seoul, South Korea.

Desert Lake Technologies, LLC is an American private company located in Klamath Falls, OR, that produces and distributes Cyactiv and AFA cyanobacteria ingredients.

ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

S.Biomedics Co. Ltd. operates as a biotechnology company. It engages in the research and development of cell therapies for regenerative biomedicine. The company was founded in August 2003 and is headquartered in Seoul, South Korea.

Two Cells Co., Ltd. engages in the research, development, manufacture, and sales of therapeutic genes, cells, drugs, diagnostic agents, chemical reagent, and medical materials. It also offers manufacture and sale of medical appliances, instruments and software related to regenerative medicine. It also handles research and development of disease treatments and cell culture system. The company was founded on April 23, 2003 and is headquartered in Hiroshima, Japan.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Nippon Menard Cosmetic Co. Ltd. develops cosmetic and health products. They manufacture and distributes cosmetics such as make-ups and perfumes, and also health food, and undergarments. The company was established in November 11, 1959 and is based in Aichi, Japan.

RBio is superior pharmaceutical production standards (GMP) in the appropriate cell therapy manufacturing facilities were seolrim derived from adipose tissue for stem cell therapy in the world No.1 in technology of rare, incurable diseases and other treatment difficult disease for clinical trials and progress and We are devoting ourselves to commercializing therapeutics.

Organ Technologies was founded to spark a new industrial revolution starting from Japan which is one of the health care’s hottest growth fields: regenerative medicine. Our mission is to promote the health and welfare of people all over the world through our novel bio-engineering technologies designed to produce realistic organs that are functionally equivalent to natural ones.

Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts is a teaching hospital of Harvard Medical School. It was formed out of the 1996 merger of Beth Israel Hospital (founded in 1916) and New England Deaconess Hospital (founded in 1896). Among independent teaching hospitals, Beth Israel Deaconess Medical Center consistently ranks in the top three recipients of biomedical research funding from the National Institutes of Health. Research funding totals nearly $200 million annually. BIDMC researchers run more than 850 active sponsored projects and 200 clinical trials. The Harvard-Thorndike General Clinical Research Center, the oldest clinical research laboratory in the United States, has been located on this site since 1973.

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Shaanxi Ruisheng Biotechnology Co., Ltd., established on 2008-03-12, Business scope includes general items:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;R&D and application of cell technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of hygiene products and single-use medical products;Cosmetics Wholesale;Cosmetics Retail;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Production of hygiene products and single-use medical products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Samaritan Pharmaceuticals, Inc. operates as an entrepreneurial biopharmaceutical company. It focuses on commercializing innovative therapeutic products to relieve patients suffering from Alzheimer's disease, cancer, cardiovascular disease, HIV, and Hepatitis C as well as commercializing its acquired marketing and sales rights, to sell marketed revenue-generating products, in Greece, and/or various Eastern European countries. The company was founded by Welter Holden on September 5, 1994 and is headquartered in Las Vegas, NV.

MEDIPHARM Co., Ltd. engages in the manufacture, distribution, and sale of medical devices, and healthcare products. Its businesses include Medical, Wooridul Chair, and Bio divisions. The Medical division offers implants, medical equipment and instruments, traction therapy products, braces, and ultrasound equipment. The Wooridul Chair division provides chairs with chest support and spine structure. The Bio division deals with stem cell research activities such as recovery effects on spinal injury, chronic bone diseases, osteoporosis, degenerative arthritis, and disk disorder. The company was founded on December 1, 2009 and is headquartered in Hwaseong-si, South Korea.